At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 18 enrolled
Drug / intervention
Calcitriol 3 mcg/g ointmentdrug
Likely dose
Calcitriol 3 mcg/g ointmentfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis
In Brief
A Phase 4 clinical trial evaluating Calcitriol 3 mcg/g ointment for Plaque Psoriasis. Completed, enrolled 18 participants across 8 sites.
Detailed Summary
The purpose of this study is to determine if the calcitriol absorption in pediatric subjects is comparable to that in adults and adolescents, with no significant impact on calcium/phosphorus metabolism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 2013
Enrollment StartMar 2013
Primary CompletionNov 2015
TodayJul 2026
First PostedJan 11, 2013
Enrollment StartMar 1, 2013
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 13.5 years ago
Interventions
Calcitriol 3 mcg/g ointmentdrug
Topical ointment; twice daily application